United Therapeutics Corp (NASDAQ:UTHR)

183.69
Delayed Data
As of May 22
 +1.08 / +0.59%
Today’s Change
84.63
Today|||52-Week Range
190.29
+41.86%
Year-to-Date

Today’s Trading

Previous close182.61
Today’s open182.58
Day’s range-- - --
Volume381,842
Average volume (3 months)719,355
Market cap$8.5B
Dividend yield--
Data as of 05/22/2015

Growth & Valuation

Earnings growth (last year)+91.46%
Earnings growth (this year)+10.17%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+15.36%
P/E ratio51.1
Price/Sales4.84
Price/Book6.97

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.20+1.14%
ALKSAlkermes Plc-0.45-0.73%
RDYDr.Reddy's Laborator...+0.61+1.07%
MDVNMedivation Inc-2.45-1.87%
Data as of 05/22/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.17
Annual revenue (last year)$1.3B
Annual profit (last year)$340.1M
Net profit margin26.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers